Comparison of circadian, weekly, and seasonal variations of electrical storms and single events of ventricular fibrillation in patients with Brugada syndrome  by Aizawa, Yoshiyasu et al.
IJC Heart & Vasculature 11 (2016) 104–110
Contents lists available at ScienceDirect
IJC Heart & Vasculature
j ourna l homepage: ht tp : / /www. journa ls .e lsev ie r .com/ i jc -hear t -and-vascu la tureComparison of circadian, weekly, and seasonal variations of electrical
storms and single events of ventricular ﬁbrillation in patients with
Brugada syndromeYoshiyasu Aizawa a,⁎,1, Seiji Takatsuki a, Yoshiaki Kaneko b, Takashi Noda c, Yoshinori Katsumata a,
Takahiko Nishiyama a, Takehiro Kimura a, Nobuhiro Nishiyama a, Kotaro Fukumoto a, Shinichi Niwano d,
Takashi Kurita e, Takeshi Mitsuhashi f, Shiro Kamakura c, Akihiko Shimizu g, Minoru Horie h,
Yoshifusa Aizawa i, Keiichi Fukuda a
a Department of Cardiology, Keio University School of Medicine, Tokyo, Japan
b Gunma University, Gunma, Japan
c National Cerebral and Cardiovascular Center, Osaka, Japan
d Kitasato University, Kanagawa, Japan
e Kinki University, Osaka, Japan
f Saitama Medical Center, Jichi Medical University, Saitama, Japan
g Yamaguchi University, Yamaguchi, Japan
h Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Shiga, Japan
i Department of Cardiology, Tachikawa General Hospital, Niigata, JapanAbbreviations: BS, Brugada syndrome; CRBBB, comp
ECG, electrocardiogram; ES, electrical storm; ICD, implan
IVF, idiopathic ventricular ﬁbrillation; MRI, magnetic re
deviation; VF, ventricular ﬁbrillation; VT, ventricular tach
⁎ Corresponding author at: Department of Cardiolo
Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-858
E-mail address: yoshiyaaizawa-circ@umin.ac.jp (Y. Aiz
1 This author takes responsibility for all aspects of the r
of the data presented and their discussed interpretation.
http://dx.doi.org/10.1016/j.ijcha.2016.05.008
2352-9067/© 2016 The Authors. Published by Elsevier Irea b s t r a c ta r t i c l e i n f oArticle history:
Received 28 March 2016
Accepted 2 May 2016
Available online 11 May 2016In patients with Brugada syndrome (BS), VF occurred predominantly during the nocturnal period. Some patients
also developed ESs. In addition to the circadian rhythm, patients showed weekly and seasonal patterns. The pa-
tients with ESs had peak episodes of VF on Saturday and in thewinter and spring, while episodes of VF in patients
with single VF events occurred most often onMonday with smaller seasonal variation. Except for age, there was
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Circadian, weekly, and seasonal variations are known to exist with
fatal ventricular tachyarrhythmias (VTAs), as well as sudden death in
patients with structural heart disease. In such patients, cardiac events
peak during the morning hours, on Monday, and during the winter
[1–4]. In contrast, ventricular ﬁbrillation (VF) in patients with Brugada
syndrome (BS), an inherited arrhythmic syndrome generally lacking
structural abnormalities, occurs at night [5]. A percentage of the patientslete right bundle branch block;
table cardioverter deﬁbrillator;
sonance imaging; SD, standard
ycardia.
gy, Keio University School of
2, Japan.
awa).
eliability and freedom from bias
land Ltd. This is an open access articlwith BS may develop electrical storms (ESs) due to VF. Recently, we re-
ported a high prevalence of early repolarization in patients with BSwho
develop ESs [6]. Subsequently, we analyzed the rhythmic occurrence of
ESs in a large sample of patients with BSwith a history of ESs. The aim of
this study was to identify the characteristic patterns of ESs in patients
with BS to understand the pathogenesis underlying ESs in these patients
and to ensure proper clinical management of this disorder.
2. Methods
2.1. Study population
We recruited 23 patients with Brugada syndrome and a history of
ESs and 21 patients with Brugada who had only single VF events as a
comparison group from multiple centers. The latter patients were
recruited from 3 institutions during the last 7 years. ESs or VF occurred
before or after the implantation of an implantable cardioverter deﬁbril-
lator (ICD). BS was diagnosed according the published criteria [5].e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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monitored for episodes of VF. Isoproterenol was administered to
control recurrent VF[6–8]. After informed consent was obtained
from the patients and family members, an ICD was implanted before
discharge. To control for possible recurrence of VF, antiarrhythmic
drugs were prescribed based on the clinical judgment of the attend-
ing cardiologists.2.2. ECG analysis
At the time of the ﬁrst hospital admission, the ECGs were analyzed
for the RR, PR and QT intervals, and the QT interval was corrected by
Bazett's formula. When J waves were present, the type (notch or
slurring), distribution pattern, and morphology of the ST segment
following the J waves were determined [7,8]. The ECGs were read by
two cardiologists. When there was disagreement regarding the J
waves, they discussed the results together to reach an agreement.2.3. Data analysis
The ECG and other clinical features were compared between the pa-
tients with ESs and those with single episodes of VF. The exact time and
day of the onset of the ES were obtained from themedical charts or ICD
records, and the rhythmicity of the episodes of VF was analyzed and
compared between the two patient groups. The acute and long-term
clinical outcomes were also compared between the two groups.Table 1








Age 42 ± 16 38 ± 13 48 ± 16 0.004
Male sex, % 42 (95.3) 23(100) 19 (90.5) 0.0802.4. Deﬁnitions
Patients with BS included in this study met the following inclusion
criteria [5]: a typical coved type Brugada ECG pattern (≥0.2 mV eleva-
tion of the J point with a type 1 ST elevation in ≥1 right precordial
lead) occurring spontaneously or after provocation with a sodium
channel blocker [9]; normal cardiac structure and function conﬁrmed
by echocardiography, MRI or catheterization; negative serology for
inﬂammatory disease and an absence of electrolyte imbalances.
Coronary spasms were excluded by a provocation test using either
acetylcholine or ergonovine maleate when informed consent was
obtained [10]. An ES was deﬁned as ≥3 separate episodes of VF/24 h.
For any early repolarization, J waves were diagnosed by the following
criteria: 1) a notch or slur in the terminal portion of the QRS complex
and 2) an amplitude of $_amp_$gt;0.1 mV above the isoelectric line in
at least two contiguous leads [11–14].
As for the rhythmicity, VF occurring between 0:00 and 6:00 was
deﬁned as nocturnal, and VF occurring between 20:00 and 8:00 was
deﬁned as nighttime. Spring, summer, autumn andwinter were deﬁned
as March to May, June to August, September to November, and
December to February, respectively.Family history, % 5 (11.4) 2 (8.7) 3 (14.3) 0.559
Number of VF 3.0 ± 4.5 4.8 ± 5.7 1 ± 0 0.004
Spontaneous type 1 29 (65.9) 18 (78.3) 11(52.5) 0.069
J wave 9 (27.3) 6 (26.1) 3 (14.3) 0.328
ECG parameters
RR (s) 0.91 ± 0.2 0.86 ± 0.2 0.92 ± 0.2 0.367
PR (ms) 161 ± 22 161 ± 22 160 ± 23 0.586
QRS (ms) 104 ± 14 104 ± 14 100 ± 12 0.062
QT (ms) 394 ± 35 394 ± 35 396 ± 39 0.309
QTc (ms1/2) 410 ± 26 410 ± 26 410 ± 29 0.939
CRBBB, % 3 (6.8) 3 (13.0) 0 (0) 0.043
Recurrence 17 (38.6) 11 (47.8) 6 (28.6) 0.188
Time to recurrence, y 2.1 ± 3.0 1.2 ± 1.6 4.3 ± 4.2 0.061
Treatment for VF
Bepridil, % 12 (27.3) 8 (34.8) 4 (19.0) 0.060
RFCA, % 2 (4.5) 1 (4.3) 1 (4.8) 0.948
CRBBB: complete right bundle branch block. RFCA: radiofrequency catheter ablation.2.5. Statistical analysis
The continuous data are presented as the mean ± standard
deviation (SD), and the categorical variables are expressed as
absolute numbers or percentages. The statistical comparisons
among the groups were made using a t-test or Mann–Whitney U-
test for continuous variables and Pearson's chi-square test for
categorical variables. The statistical analyses were performed with
SPSS (Statistical Package for the Social Sciences), version 12.0
software (SPSS Inc., Chicago, IL, USA). A two-sided p of
$_amp_$lt;0.05 was considered statistically signiﬁcant.
Written informed consent was obtained from all patients at each
institution before the invasive procedures. This study was approved by
the Ethics Committee of Keio University School of Medicine.3. Results
3.1. Patient characteristics
Forty-four patients who met the inclusion criteria were enrolled
in this study. ESs developed in 23 patients, and 21 patients experi-
enced single VF events. The mean age was signiﬁcantly younger in
the ES group (38 ± 13 vs. 48 ± 16 years, P = 0.004). Two patients
in the ES group and one from the non-ES group had a family history
of sudden cardiac death or Brugada syndrome (Tables 2 and 3). All
episodes of ES and all single VF episodes occurred outside the hospi-
tal and were successfully deﬁbrillated by an external deﬁbrillator or
ICD. The average number of VF events occurring in the ES patients
was 4.8 ± 5.7 (Tables 1 and 2, P $_amp_$lt; 0.0001). Fig. 1 shows
the onset of VF triggered by frequent premature ventricular com-
plexes (patient no. 14, Table 2).
A spontaneous type 1 pattern was observed in 78.3% of patients in
the ES group and in 52.4% of patients in the non-ES group (P =
0.069). The remaining patients underwent a provocation test for BS
using pilsicainide, a class Ic drug, and the results were uniformly
positive. The prevalence of J waves, the ST morphology following the J
waves and their distribution patterns did not differ. There was no
difference in the other ECG parameters, including the RR, PR, QRS, QT,
or QTc intervals between the patients with ESs and those with single
VF events, but complete right bundle branch block (CRBBB) was
observed more frequently in the ES group (P = 0.043, Table 1). None
of the patients developed any chest pain suggestive of myocardial
ischemia prior to the onset of VF or an ES. There was no evidence of
signiﬁcant stenosis or coronary spasms in the patients who underwent
a provocation test: 10 in the ES group and 20 in the non-ES group.
Inﬂammatory disease and electrolyte imbalances were also ruled out
by serological tests and blood chemistry.3.2. Circadian pattern of the VF occurrence
Fig. 2 shows the circadian distributions of the timing of VF events in
37 patients. Similar percentages of ESs and VF events occurred between
0:00 and 6:00 (nocturnal) in 10/20 (50.0%) vs. 8/17 (47.1%), and be-
tween 20:00 and 8:00 (nighttime) in 15/20 (75.0%) vs. 13/17 (76.5%),
respectively (Fig. 2A and B). None of the patients who experienced
these episodes were nighttime workers. Except for two patients who
Table 2
Clinical characteristics of the 23 patients with BS demonstrating an ES.
No. Age Sex FH No. of VF Month Week Time Status of VF onset Pharmacological therapy Recurrence (yrs after ES) Outcome
1 49 M SD 3 April Saturday 7:06 nd – Yes (2.3) Alive
2 26 M – 3 December Thursday 21:37 Awake ISP/cilostazol – Alive
3 42 M – 30 January Friday 3:00 Sleep – – Alive
4 25 M – 4 January Saturday 21:20 Alcohol – Yes (0.2) Died
5 21 M SD, BS 3 August Wednesday 2:38 Sleep – Yes (0.5) Alive
6 21 M – 3 June Saturday 3:20 Alcohol – Yes(0.1) Alive
7 36 M – 9 May Tuesday 2:13 Sleep – – Alive
8 33 M – 3 July Tuesday 14:30 Awake – Yes (0.25) Alive
9 53 M – 3 June Thursday 22:38 nd – – Alive
10 38 M – 4 March Monday 1:43 Sleep – – Alive
11 36 M – 4 December Saturday nd nd ISP/Bepridil – Alive
12 61 M – 7 November Saturday 14:45 nd Bepridil Yes (0.3) Alive
13 42 M – 3 May Sunday nd nd ISP/Bepridil Yes (4.8) Alive
14 51 M – 4 February Saturday nd nd ISP/Bepridil Yes (nd) Alive
15 39 M – 3 March Tuesday 4:27 Sleep ISP/Bepridil Yes (0.7) Alive
16 30 M – 3 December Thursday 3:30 Sleep Quinidine Yes (3.3) Alive
17 27 M – 3 July Tuesday 11:30 nd Disopyramide Yes (0.1) Alive
18 70 M – 3 October Sunday 0:22 Sleep ISP/Denopamine – Alive
19 29 M – 3 May Sunday 2:47 Sleep Quinidine – Alive
20 42 M – 3 February nd 22:18 nd Bepridil – Alive
21 38 M – 3 nd nd 3:22 Sleep Amiodarone – Alive
22 50 M – 3 nd nd 16:28 nd Bepridil – Alive
23 19 M – 3 April nd 21:18 nd Bepridil – Alive
BS: Brugada syndrome, ISP: isoproterenol, M: male, nd: not determined. SD: sudden death, yrs: years.
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curred while the patients were at home and in a resting state or during
sleep (Table 2).
3.3. Weekly pattern of VF
Fig. 3A shows the weekly distribution of the timing of the VF events
in 34 patients. Overall, there were 2 peaks at the beginning of the week
and on the weekend: Tuesday and Saturday. ESs peaked on Saturday
(P $_amp_$lt; 0.001 vs. other weekdays), while single VF episodes
peaked on Monday (P = 0.097 vs. other week days) (Fig. 3B, C). Epi-
sodes of VF occurred more frequently during the weekend (Saturday
and Sunday) in the ES group compared with the single VF group:
47.4% vs. 12.3%, respectively (P = 0.035).Fig. 1. Frequent premature ventricular complexes and the onset of ventricular ﬁbrillation. A: Tw
ventricular outﬂow tract region. B: VF follows a short–long–short sequence of premature vent
leads, and J waves in the inferior leads are present.3.4. Seasonal pattern of VF occurrences
Overall, the monthly distribution patterns in 36 patients showed 3
peaks in January, June and December (Fig. 4A). ESs peaked in May and
December. The incidence of ESs was higher during the winter and
spring compared with other seasons: 66.7% vs. 33.3% (P = 0.012,
Fig. 4B). However, such seasonal differenceswere not observed in single
VF episodes: 46.7% vs. 53.3% (P = 0.835, Fig. 4C).3.5. Management of VF and the outcomes
ESs were controlledmainly by intravenous administration of isopro-
terenol (Table 2). One patient in the ES group underwent catheterelve-lead ECG recorded prior to the onset of VF. Frequent PVCs originated from the right
ricular complexes (patient no. 11). Both a coved type ST elevation in the right precordial
Fig. 2. Circadian pattern of an ES and a single VF episode (n=37). The overall circadian distribution shows a predominant occurrence of VF during the nocturnal period (A). Therewas no
difference in the pattern of episodes of VF between the patients with an ES (B) and those with a single VF episode (C).
Fig. 3.Weekly pattern of episodes of VF (n= 34). Overall, therewere 2 peaks on Tuesday and Saturday (A). ESs peaked on Saturday (P $_amp_$lt; 0.001 vs. other weekdays), while single
VF episodes peaked on Monday (P = 0.097 vs. other weekdays) (B, C). VF occurred more often in the ES group during the weekend (Saturday and Sunday) compared to the single VF
group: 47.4% vs. 12.3%, respectively (P = 0.035).
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Fig. 4. Seasonal pattern of ES and single VF events (n=36). Overall, themonthly distribution patterns in 36 patients showed 3 peaks in January, June andDecember (A). ESs peaked inMay
and December, and incidence of ESs was higher during the winter and spring compared with other seasons: 66.7% vs. 33.3% (P= 0.012, B). However, such seasonal differences were not
observed in single VF: 46.7% vs. 53.3% (P = 0.835, C).
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the right ventricular outﬂow tract (Table 2, patient no. 2).
All 44 patients were implanted with an ICD and were discharged
alive. For chronic therapy, the following antiarrhythmic drugs were
prescribed to a limited number of patients based on the clinical
judgment of their attending physician: bepridil (n = 8), quinidine
(n = 3), denopamine (n = 2), disopyramide (n = 1), cilostazol (n =
1), or amiodarone (n = 1) in the ES patient group, and bepridil (n =
4), quinidine (n = 2) or mexiletine (n = 1) in the non-ES patient
group (Tables 2 and 3). Bepridil was used most frequently for its Ito
blocking effects.Table 3
Clinical characteristics of the 21 patients with BS demonstrating no ESs.
No. Age Sex FH No. of VF Month Week Time Statu
1 13 F – 1 October Tuesday 10:00 Runn
2 51 M – 1 January Tuesday 22:00 Awa
3 38 M – 1 July Wednesday 13:00 Awa
4 67 M – 1 June Monday 19:20 Awa
5 45 M – 1 January Monday 0.00 nd
6 45 M – 1 December Monday 4:00 Awa
7 47 M – 1 October Sunday 1:31 nd
8 52 M – 1 January Tuesday 5:00 Sleep
9 63 M – 1 nd nd 4:11 Sleep
10 25 M – 1 nd nd 5:17 Sleep
11 69 M – 1 nd nd 16:00 Awa
12 60 M – 1 nd nd 2:33 nd
13 34 M – 1 nd nd 22:00 Awa
14 37 M – 1 October Friday nd Awa
15 55 M SCD 1 July Wednesday 1:20 nd
16 44 M – 1 June Wednesday nd Awa
17 78 F – 1 June Monday nd Awa
18 35 M – 1 May Thursday 13:40 Awa
19 42 M – 1 March Saturday 20:40 Awa
20 M – 1 nd nd nd nd
21 56 M – 1 December Thursday 21:00 Awa
a Terminated because of skin rash. nd: not determined.During the follow-up period of 6.2 ± 4.9 years, VF recurred in 11
patients (47.8%) in the ES group (Table 2) and 6 patients (28.6%) in
the single VF group. The long-term recurrence rate was higher in the
ES group, although not signiﬁcantly (P= 0.188). Among 14 ES patients
and 6 non-ES patients on antiarrhythmic drugs, VF recurred in 6/14
(42.9%) and 1/6 (16.7%), respectively, whereas among 9 ES and 15
non-ES patients on no antiarrhythmic drugs, VF recurred in 5 (55.6%)
and 5 (33.3%), respectively. These differences were not signiﬁcant.
One patient who underwent catheter ablation was free from recurrent
VF. The time to recurrence of VF was shorter for patients with ES com-
pared with those with single VF, although this was not signiﬁcants of VF onset Pharmacological therapy Recurrence (yrs after ES) Outcome
ing? – – Alive
ke – – Alive
ke – – Alive
ke – – Died
Quinidine Yes (0.2) Alive
ke – – Alive
– Yes (4.1) Alive
– Yes (8.1) Alive
Bepridil/Mexiletine – Alive
Quinidinea – Alive
ke Bepridil – Alive
– – Alive
ke Bepridil – Alive
ke Bepridil – Alive
– – Alive
ke – – Alive
ke – Yes (8.0) Alive
ke – Yes (0.1) Alive
ke – - Alive
– Yes (nd) Alive
ke – – Alive
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was not different between the patients with and without antiarrhyth-
mic drugs (1.6 ± 1.0 vs. 2.7 ± 3.6 years, P = 0.480). One patient in
each group died from refractory recurrent ESs followed by infection
and heart failure (Tables 2 and 3).4. Discussion
In patients with BS who experienced ≥1 VF episode, the patients
with ESs were younger than those with single VF events, but there
was no difference in other clinical features. Both ESs and single VF
events occurred similarly during the night: between 0:00 and 06:00 or
20:00 and 08:00. However, episodes of ESs peaked on Saturday and
occurred more often during the winter and spring, whereas single VF
events peaked on Monday with smaller seasonal variation. Patients
with Brugada syndrome and VF admitted over the weekend or in the
winter and spring may require intensive care monitoring for possible
recurrence of arrhythmias in the form of an ES.4.1. Circadian rhythm of the VF occurrences
Matsuo et al. reported that in BS, VF occurs more frequently at night
than at other times of the day and more frequently during sleep than
during waking hours [15]. Subsequently, Takigawa et al. reported that
VF associated with BS occurs more frequently between midnight and
6:00 am [18]. Consistent with earlier reports, in the present study,
both ESs and single VF events in patients with BS occurred predomi-
nantly at night or during the nocturnal period (Fig. 2). The circadian
rhythm of VF in BS is quite different from the pattern of sudden cardiac
death or VTAs in patients with structural heart disease [1].
Mechanistically, vagal stimulation or withdrawal of sympathetic
activity is shown to augment the transient outward currents (Ito) and
suppress the ICa-L currents, which in turn lead to a shortening of the
action potential duration or a loss of the dome of the action potential
[19]. These changes in ionic currents are considered to exaggerate
coved type ST elevation.
Clinically, it is well known that the ECG pattern is modulated by
many factors, including cholinergic or adrenergic activities [20,21].
Furthermore, the ECG exhibits a typical coved type ST elevation at the
time that VF occurs. Unmasking of a typical ECG pattern in BS can also
be induced during the recovery phase of exercise [22], during glucose-
induced insulin secretion [16], and when the stomach is full after a
large meal [17]; all conditions associated with increased vagal tone.
Both the accentuated ECG pattern and the predominant occurrence of
VF during the nocturnal period or at night conﬁrm the close relationship
between the increased vagal tone (with or without a withdrawal of
sympathetic nerve activity) and the occurrence of VF. Although both
ES and single VF episodes occurred similarly during the nocturnal
period, patients who experienced ESs were younger. Young people are
known tohavemore dominant vagal activity compared to older individ-
uals, which can be a potential risk for the occurrence of VF in BS.4.2. Weekly rhythm of the VF occurrences
We also made a ﬁrst time observation that weekly and seasonal
patternswere different between the ES and single VF events. ESs peaked
on Saturday, while single VF events peaked on Monday (Fig. 3). These
weekly patterns of episodes of VF are difﬁcult to explain and may be
related to working habits and social activities that modulate the
autonomic tone and the arrhythmogenic substrate in BS. Vagal tone is
higher in a relaxed state, which is more likely to be present during the
weekend. Two patients also developed an ES during heavy alcohol
intake on a weekend. The reason why single VF events mostly
occurred on Monday requires further explanation (Fig. 3).4.3. Seasonal rhythm of the VF occurrences
In the analysis of the data of appropriate ICD shock episodes for VF
events in patients with BS, Takigawa et al. observed a seasonal peak
between March and June [18]. This was in contrast to the report by
Kim et al. who analyzed VF events in patients BS who had ICDs [19]. Al-
though the patients with early repolarization syndrome had a seasonal
peak from spring to summer, they observed no signiﬁcant seasonal peak
in patients with BS. In the current study, the overall seasonal VF events
showed 3 peaks in January, June and December, and more ESs (66.7%)
occurred during thewinter and spring; however, 33.3% occurred during
the rest of seasons (P = 0.012, Fig. 4). The reasons for the discrepant
ﬁndings among the reports are not readily apparent, although there
are probably several contributing factors, such as a difference in the
patient populations, type of VF occurrence (ES vs. single VF episode),
lifestyles, social activities and different climates. A further study that
includes a larger number of patients is needed.
During cold winters, the plasma catecholamine levels are higher,
which might trigger an acute myocardial infarction and sudden death
in the general population [1–4]; however, how this might be related
to the occurrence of VF in BS is unknown. Febrile illnesses are also
more common during cold seasons and can precipitate an episode of
VF in BS [23]. None of the patients of the present study developed VF
in association with a febrile illness. The difference in the seasonal
patterns of episodes of VF between the patients with ESs and those
with single VF episodes is another dilemma to be solved.
4.4. Future direction
Clinical studies with a larger number of patients are required to
uncover the underlying mechanism driving the rhythmic pattern of
episodes of VF in patients with BS. The existence of a master clock
known as the suprachiasmatic nucleus with associated circadian genes
may provide some insight into this mechanism (Per, Cry, Bmal1 and
Clock). Evidence suggests that the circadian transcription of ion
channels may contribute to the development of cardiac arrhythmias.
For example, Klf15 (krüppel-like factor 15) controls the rhythmic
expression of KChIP2 [20], and Bmal1 (Brain and Muscle Arnt-like
1) regulates SCN5A [21]. Future studies should investigate the circadian
expressions of various ion channels in humans in general as well as in
patients with BS.
4.5. Limitations
Although the present study included the largest number of ES
episodes in patients with BS and studied the circadian patterns of VF
events, further conﬁrmation is still needed in a larger number of
patients.
Except for age, there was no difference in the clinical and ECG
features between the patients with BS and ESs and those with single
VF episodes. We were unable to conﬁrm speciﬁc factors involved in
the development of ESs. Furthermore, the role of vagal tone in the
speciﬁc weekday or season in producing a rhythmicity of VF was not
evident. Although ECG ﬁndings can be variable, they were not analyzed
in a serial manner. Several responsible genes have been reported in BS,
and genetic studies may help deepen our understanding of the
rhythmicity of ES and VF events in BS.
5. Conclusions
Both ES and single VF events occurred during the nocturnal period of
the day in BS. However, ESs occurred most frequently on Saturday and
in the winter and spring, while single VF events occurred more
frequently on Monday with smaller seasonal variations. The pathogen-
esis and precipitating factors responsible for the differing rhythmicity
110 Y. Aizawa et al. / IJC Heart & Vasculature 11 (2016) 104–110of episodes of VF between ESs and single VF events must be determined
to understand the pathogenesis of BS.
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